28/02/2011
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
S. R. Durham, A. O. Birk and J. S. Andersen
Allergy Volume 66, Issue 1, pages 120–123, January 2011
Haga un comentario